GZMB and neoplasm: In order to determine if the presence of tumor scIgGs impacted NK cell activation and cytotoxicity, we measured granzyme B, perforin, and natural cytotoxicity triggering receptor 1 (NCR1/NKp46/CD335) as molecular signatures of NK cell activation.